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A prospective study of bowel preparation for colonoscopy
with polyethylene glycol-electrolyte solution versus sodium
phosphate in Lynch syndrome: a randomized trial
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 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract Lynch gene carriers undergo regular surveil-
lance colonoscopies. Polyethylene glycol-electrolyte solu-
tion (PEG) is routinely prescribed for bowel cleansing, but
often poorly tolerated by patients. Sodium phosphate (NaP)
may be an alternative. Prospective and random comparison
of bowel preparation with PEG and NaP on colon cleansing
and patients’ acceptance. Patients, who previously under-
went a colonoscopy, were invited to participate and ran-
domly assigned to either PEG or NaP. They were asked to
fill in a questionnaire about preparation tolerability and
future preferences. The endoscopist filled out a report about
the quality of colon cleansing. 125 Patients were included
in the study. Nine (7%) were excluded because of missing
data. The remaining 116 patients (53 PEG and 63 NaP) were
included in the analysis. Baseline characteristics did not
differ between groups. Before colonoscopy 20 (38%)
patients using PEG experienced the preparation almost
intolerable, in contrast to 7(11%) of those using NaP
(P = 0.001). Eleven patients in the PEG group and 48 in
the NaP group would prefer NaP in the future. The colon-
oscopy was poorly tolerated in 17% of the individuals in
both groups (P = 0.963). The endoscopist observed a more
than 75% clean colon in 83% of patients on PEG and in 71%
of patients on NaP (P = 0.076), however the coecum (P =
0.025) and ascending colon was cleaner after PEG. Lynch
patients tolerated NaP better and preferred this formula for
future bowel preparation. Colon cleansing was suboptimal
with both treatments with a tendency towards a cleaner
proximal colon with PEG.
Keywords Lynch syndrome  Colonoscopy 
Polyethylene glycol  Sodium phosphate
Abbreviations
PEG Polyethylene glycol-electrolyte solution
NaP Sodium phosphate
MMR Mismatch repair
Introduction
Up to 5% of all colorectal cancer cases are attributed to the
Lynch syndrome [1].Lynch syndrome is caused by germ
line mutations in one of the mismatch repair (MMR) genes
MLH1, MSH2, MSH6 or PMS2 [2]. Lynch syndrome gene
carriers are recommended to undergo regular endoscopic
surveillance of their colon. This surveillance is preferably
carried out by colonoscopy, [3, 4] in order to detect ade-
nomas or less frequently early stages of colon cancer. It is
important that the complete colonic mucosa can be
inspected, especially the proximal colon, since most tumors
in Lynch syndrome develop in this part of the colon. For
inspection, a meticulously clean colon is therefore a pre-
requisite. Various colon-cleansing solutions have been
M. W. J. van Vugt van Pinxteren (&) 
M. C. A. van Kouwen  M. G. H. van Oijen  F. M. Nagengast
Department of Gastroenterology and Hepatology, Radboud
University Nijmegen Medical Centre, P.O.Box 9101,
6500 HB Nijmegen, The Netherlands
e-mail: m.vanvugt@mdl.umcn.nl
M. G. H. van Oijen
Department of Gastroenterology and Hepatology, University
Medical Centre Utrecht, P.O.Box 85500, 3508 GA Utrecht,
The Netherlands
T. van Achterberg
Scientific Institute for Quality of Healthcare, Radboud
University Nijmegen Medical Centre, Nijmegen, P.O.Box 9101,
6500 HB Nijmegen, The Netherlands
123
Familial Cancer
DOI 10.1007/s10689-012-9517-7
studied in the past. Of these, a polyethylene glycol-elec-
trolyte solution (PEG) is routinely prescribed for bowel
cleansing, but it is often poorly tolerated [5–8]. Sodium
phosphate (NaP) may be an effective alternative, and is
often better tolerated because of the small amount of liquid
intake. However, it has other disadvantages like acute
phosphate nephropathy and should be used with caution by
at risk individuals and not be prescribed to patients with
cardial and/or renal failure [3, 5, 7–12]. Earlier studies with
PEG and NaP have shown an excellent clean colon in
18–80% [7–12]. Patients mentioned equal acceptability
about the bowel cleansing. The tolerability of bowel
cleansing was about 60% [3, 6, 8–10, 12–14]. In these
earlier studies it was often not clear if the study participants
underwent a surveillance colonoscopy previously, nor was
information about special patient groups available. The aim
of this study was to randomly compare the effects of
preparation on bowel cleansing with PEG or NaP and to
evaluate the acceptance of the two solutions by Lynch
syndrome gene carriers who used PEG as colon cleansing
in the past.
Methods
Patients
This single blinded study was carried out at the department
of Gastroenterology and Hepatology in a Dutch University
hospital. During 1 year, Lynch syndrome gene carriers,
who were scheduled for a surveillance colonoscopy, were
asked to participate in the study. They were enrolled in a
surveillance colonoscopy program and underwent at least
one colonoscopy previously at which they used PEG as
preparation on bowel cleansing. Patients with a history of
colonic surgery were excluded. All procedures took place
in the afternoon. Participants were randomly and single-
blindly assigned to either PEG (Norgine bv, Amsterdam,
the Netherlands) or NaP (Ferring, Hoofddorp, the Netherlands).
Lynch syndrome gene carriers are generally healthy per-
sons without physical and medical restrictions to use NaP.
Patients who were assigned to the PEG-group were
given a special dietary prescription. 2 days before colon-
oscopy only lightly digestible products will be consumed
and at the day before colonoscopy only fluid products. In
addition, at the day before colonoscopy they had to use 15
gram magnesium sulfate and 10 mg bisacodyl (both orally)
(Boehringer Ingelheim, Alkmaar, the Netherlands). At the
day of colonoscopy patients had to use 4 litres PEG or at
least enough until the stool is clear. PEG was not given as a
split-dose. Patients who were assigned to the NaP group
used a lightly digestible breakfast and lunch at the day
before colonoscopy, as prescribed in the instructions for
use. After lunch at the day before colonoscopy, they con-
sumed only clear fluids, at least 3 litres until the colonos-
copy. In the evening before colonoscopy 45 ml of NaP had
to be taken. Three hours before colonoscopy another 45 ml
of NaP had to be used. Informed consent was obtained and
the study was approved by the local Medical Ethical
Committee.
Instruments
The quality of bowel cleansing was assessed for each
segment of the colon (descending, transverse and ascend-
ing colon and the coecum) and graded as excellent (no
fecal matter), good (small amounts of thin, liquid fecal
matter; easy to remove), fair (moderate amounts of thick
liquid fecal matter; difficult to remove) and poor (large
amounts of thick liquid or solid fecal matter; not to
remove) (Table 1).
During the day of preparation before colonoscopy and
1 week after colonoscopy, patients were asked to fill in a
questionnaire about their experiences with the dietary
pattern, potential interference with daily activities, toler-
ance and side effects of the bowel preparation and the taste
of the liquid. They were also asked to mention their pref-
erences for a bowel preparation in the future. The ques-
tionnaires were filled in at home before and 1 week after
colonoscopy. The endoscopist (blinded for the way of
bowel cleansing) filled out a report about the effectiveness
of bowel cleansing and the duration of the introduction
time and the time of the whole colonoscopy ranked as
12.5 min or less, 12.5–25 min, 25–37.5 min and more than
37.5 min. The endoscopy nurse (also blinded for the way of
bowel cleansing) filled out a report about the observation of
signs of pain during colonoscopy. The pain score was
ranked on a visual analog score from 1 to 5 as no pain (1);
mild pain (2); moderate pain (3); severe pain and more
sedation is necessary (4) and interrupted colonoscopy
because of very severe pain (5).
Statistical analysis
Data were collected and entered into an electronic data-
base. All calculations were carried out using the Statistical
Package for the Social Sciences Program (SPSS version
Table 1 Cleansing grading score by the endoscopist
Excellent No fecal matter in the colon
Good Small amounts of thin, liquid fecal matter in the colon;
easy to remove
Fair Moderate amounts of thick liquid fecal matter in the
colon; difficult to remove
Poor Large amounts of thick liquid or solid fecal matter in the
colon; unable to remove
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16.0 (SPSS, Chicago, Illinois, USA). Frequency tables
were provided for description of patients and bowel
cleansing characteristics and were compared between
groups. Descriptive statistics were computed for all vari-
ables. These included means, medians and standard devi-
ations. Pearson’s Chi-square test was used to analyze
associations between baseline characteristics, differences
for PEG and NaP, quality and side effects of bowel
cleansing and results of cleansing. P value below 0.05
(two-sided) was considered statistically significant.
Results
During a 1 year study period, 125 consecutive Lynch gene
carriers participated in the study (100%). Of these 125
patients, nine (7%) were excluded because of missing data;
they did not send back one or both questionnaires. The
remaining 116 patients (M/F 58/58, mean age 50 ± 30
years) were included in the analysis. Fifty-three patients
received PEG and 63 NaP. Twenty-three (20%) partici-
pants underwent one colonoscopy in the past, 59 (51%)
underwent 2-5 colonoscopies, 31 (27%) had 6-10 colo-
noscopies and 3 (2%) patients underwent more than 10
colonoscopies (median 3).
In only one patient the special diet at the day before
colonoscopy interfered with daily activities (0.6%). Eighty
four percent of all patients did not mention any or only little
problems at the day before the colonoscopy. At the day of
colonoscopy the preparation with the laxative interfered with
their daily activities in nineteen patients (16%). Twenty
patients using PEG (38%) found the preparation almost
intolerable in contrast to seven (11%) patients using NaP
(P = 0.001) before colonoscopy. A week after colonoscopy
24 (45%) patients using PEG and 47 (75%) of those using
NaP evaluated the preparation as tolerable (P = 0.001).
Twenty-two (42%) patients using PEG and 11 (17.5%) using
NaP mentioned the preparation as neutral (P = 0.004). At
least seven (13%) patients using PEG (four of them evalu-
ated the preparation as more difficult afterwards) and five
(8%) patients using NaP) (the same five patients who
communicated this before) evaluated the preparation as
intolerable (Fig. 1). The most commonly mentioned side
effects of the preparation were nausea, abdominal cramps
and flatulence; these side effects were mentioned in the
instructions of PEG and NaP. Patients also commonly
mentioned that they suffered from feeling cold; this was not
mentioned as a possible side effect in the instructions of
PEG and NaP (Table 2). Sixty percent of all patients using
PEG and 58% of patients using NaP used 4 l of fluids or
more before colonoscopy; equal to or more than prescribed.
Twenty-one patients (18%) had a preference for using
PEG in the future (six of them randomized to NaP in this
study), 59 (51%) preferred to use NaP (11 of them ran-
domized to PEG in this study) and 31 (27%) of the patients
had no preference (22 PEG/9 NaP). Five patients (4%) did
not mention their preference. In nine (17%) of the indi-
viduals using PEG and in 11 (18%) of the NaP participants
the colonoscopy was equally poorly tolerated.
The endoscopist (n = 8) reported a clean colon in 44
participants (83%) using PEG and also in 44 patients (71%)
using NaP. In 19 (36%) of the total group of PEG users and
13 (21%) of the NaP users the endoscopist observed a more
than 75% complete clean colon (P = 0.076). In 42% of the
PEG group the coecum was excellent clean, compared to
22% in the NaP group (P = 0.02) (Table 3). In 11% the
ascending colon was poorly cleaned in the NaP group,
compared to 2% in the PEG group (P = 0.05). The intro-
duction time into the coecum and the duration of the whole
colonoscopy did not significant differ between both groups.
In both PEG (29%) and NaP (25%) the introduction time
into the coecum was about 12.5 min (P = 0.645) while in
PEG (9%) and NaP (13%) the introduction time has taken
more than 37.5 min. The majority of patients (80%)
received midazolam as sedation during the colonoscopy.
During the colonoscopy the endoscopy nurse observed pain
on a visual analog score in 73 (33 PEG and 40 NaP) of all
patients (47%); of them 17 (15%) suffered from a lot of
pain (6 PEG and 11 NaP). In one case (NaP) the
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Fig. 1 Patients’experience about bowel cleansing
Table 2 Side effects of bowel preparation (measured before
colonoscopy)
PEG-group (n, %) NaP-group (n, %) P value
Nausea 24 (21) 20 (17) 0.134
Vomiting 4 (3) 6 (5) 0.706
Abdominal
cramps
23 (20) 27 (23) 0.953
Flatulence 15 (13) 13 (11) 0.336
Physical cooling 34 (30) 34 (30) 0.267
Insomnia 8 (7) 8 (7) 0.709
Colon cleansing in Lynch syndrome
123
colonoscopy was stopped because of extreme pain. Fifty-
five patients mentioned complaints (flatulence or abdomi-
nal pain) after colonoscopy, which always disappeared
within 24 h.
Discussion
Persons at risk for colon cancer, especially Lynch syndrome
gene carriers, benefit from regular surveillance colonos-
copies [15]. For an optimal detection of colonic neoplasia a
clean colon is very important [11]. To achieve a clean colon,
compliance with the bowel preparation regimen is neces-
sary. The most commonly used bowel cleansing solutions
are often burdensome to patients because of the large
amounts of fluids and their bad taste [11]. To our knowledge
no information is available about the experience of bowel
preparation in Lynch patients in a regular colonoscopy
program. In this study all patients were able to tolerate the
preparation regime, in contrast to some other studies [9, 13].
Clean colon
In patients with Lynch syndrome the increased risk for
developing colon cancer is highest in the colon proximal to
the splenic flexure [16]. It is therefore particularly impor-
tant to examine this part meticulously and it is essential
that this part of the colon is excellently cleaned. We found
a comparable clean colon in the PEG and NaP group [17].
In assessing this, we used the same criteria for ‘‘poor’’
clean, ‘‘fair’’ clean, ‘‘good’’ clean and ‘‘excellent’’ clean
colon as described in previous studies [5, 7, 8, 11–14, 18].
Also the same segments of the colon were evaluated [7, 9,
11, 12, 18]. It was remarkable that, in contrast to other
studies, we found an excellent clean colon only in 27.6% of
the participants, regardless of the bowel cleansing. A sig-
nificant difference in an excellent clean coecum was found
in favour for PEG preparation (42% vs. 22%). Moreover, in
the ascending colon the quality of bowel cleansing was
significantly more poor in the NaP group (11% vs. 2%).
The cleansing efficacy of PEG in non-Lynch patients was
comparable for both left and transverse colon, but the
cleanliness was also superior in the coecum and ascending
colon in a previous Dutch study [9].
Tolerance
Nausea was mentioned as a moderate side effect of the
colon cleansing in both PEG and NaP groups; we found no
difference between the groups, which was in accordance
with other studies [5, 7, 8, 11, 14].
In our study both PEG and NaP users often suffered
from feeling cold; in other studies no information was
found about this side effect. The 60% of patients, who
drank 4 litre fluids or more, did not consume the drinks at
the same time. Patients who used PEG, drank this amount
at the day of colonoscopy and patients’ who used NaP,
drank this amount in 2 days; nevertheless many of them
mentioned this side effect.
Twenty-five percent of all patients poorly tolerated the
cleansing preparation; however, a week after the colonos-
copy only 10% of the participants mentioned that the
preparation was not tolerable. Probably not only the taste
and the amount of the cleansing liquid are of influence on
patients’ perception. It is also possible that fear for the
colonoscopy itself, the fear for the outcome of the colon-
oscopy and the consequences of these results to the future
influenced patients’ perception.
Overall, in contrast to some other studies, [12, 14]
because of the amount of the liquid, the acceptance of the
bowel preparation was in favour for NaP, however the taste
of the liquid was similar for both groups [9].
Pain
The information of the endoscopy nurse about the observation
of pain during the endoscopy was in line with the patients’
information about their experience of the colonoscopy. In the
PEG group, there was a tendency towards less pain.
Preference
Patients who used PEG or NaP most of time prefer to use the
same formula for bowel cleansing in the future or they
Table 3 Quality of bowel cleansing for segments of the colon (n, %)
Coecum Ascending colon Transverse colon Descending colon
PEG NaP PEG NaP PEG NaP PEG NaP
Excellent 22(42)# 14(22) 19(36) 14(22) 17(32) 12(19) 14(26) 12(19)
Good 16(30) 20(32) 16(30) 26(41) 24(45) 32(51) 25(47) 25(40)
Fair 12(22) 19(30) 17(32) 16(26) 11(21) 18(29) 12(23) 24(38)
Poor 3(6) 10(16) 1(2)# 7(11) 1(2) 1(1) 2(4) 2(3)
# P = \ 0.05 in favour of PEG
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mentioned no preference. In the total group 51% was in favour
of NaP. The same acceptability was found in other studies [11,
14]. Thirty-three percent of the users in the PEG group, who
did not endure PEG in the present study, mentioned a prefer-
ence for NaP, even although they did not know anything about
the liquid’s taste or possible side effects of NaP.
In our study PEG and NaP are both effective as preparation
for bowel cleansing with a tendency to a cleaner colon with
PEG. This is in accordance with some earlier studies, [5, 6, 8,
9, 11, 12, 14, 19, 20] but the most important observation was a
significantly more clean proximal part of the colon with PEG
preparation [21]. This last finding is important with regards to
the afore-mentioned high risk of neoplasia in the proximal
colon in Lynch syndrome.
To our knowledge this is the first study relating to bowel
cleansing in Lynch gene carriers. Although this study was
conducted in a small group of gene carriers, who visited the
outpatient clinic in one hospital, we conclude that bowel
preparation, in this representive group of Lynch gene carriers,
is not optimal with both preparations. In the proximal part of
the colon PEG seems to clean the mucosa better than NaP.
These findings suggest that for optimal (proximal) bowel
cleansing in Lynch syndrome PEG is a better option than NaP.
The efficacy of bowel cleansing should always be more
important than patient preferences in determining the choice of
bowel preparation. Maybe other reasons than taste and amount
of cleansing liquid are of influence at patients’ acceptability for
bowel cleansing. So it seems mandatory that in patients at high
risk of (proximal) colon cancer, better cleaning regimes as well
as patients’ acceptance should be developed and investigated.
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